Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E2 in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 1, 2001, Pages 7-14

  Rady, Jodie J ^a,b   Campbell, William B ^b   Fujimoto, James M ^a,b  

^a CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; MORPHINE; NOCICEPTIN; OPIATE AGONIST; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ARTICLE; DESENSITIZATION; DOSE RESPONSE; DRUG MECHANISM; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL;

ANALGESICS, OPIOID; ANIMALS; BRAIN; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALIN, LEUCINE; INDOMETHACIN; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MORPHINE; OPIOID PEPTIDES; PAIN MEASUREMENT; RECEPTORS, PROSTAGLANDIN; SPINAL CORD; SUBSTANCE P;

EID: 0035193092     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Involvement of dynorphin A and not substance P in the spinal antianalgesic action of capsaicin against morphine-induced antinociception in mice
2. 2 receptor
3. 2 is noradrenergic terminal dependent
4. The effect of various neurohormonal modulators on the activity of morphine and the narcotic antagonists in the tall flick and phenylquinone test
5. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
6. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse
7. Characterization of nociceptin hyperalgesia and allodynia in conscious mice
8. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ
9. Supraspinal neurotensin antianalgesia in mice is due to spinal cholecystokinin
10. Intrathecal morphine in mice: A new technique
11. Nociceptin/orphanin FQ induced nociceptive responses through substance P release from peripheral nerve endings in mice
12. Antinociceptive and morphine modulatory actions of spinal orphanin FQ
13. A simplified method of evaluating dose-effect experiments
14. The effect of morphine on formalin-evoked behavior and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats
15. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
16. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
17. 2 to mice
18. 2-induced allodynia in conscious mice
19. 2
20. Orphanin FQ is a functional anti-opioid peptide
21. Functional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQ
22. Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice
23. Antinociception mediated by the periaqueductal gray is attenuated by orphanin FQ
24. Prostanoid receptors: Structure, properties, and functions
25. Identification and characterization of an endogenous ligand for opioid receptor homologue ROR-C: Its involvement in allodynic response to innocuous stimulus
26. A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin
27. Antianalgesic action of dynorphin A mediated by spinal cholecystokinin
28. Morphine tolerance in mice changes response of heroin from μ to δ opioid receptors
29. Pentobarbital antagonism of morphine analgesia mediated by spinal cholecystokinin
30. Orphanin FQ: A neuropeptide that activates an opioid like G-protein-coupled receptor
31. Pharmacological characterizatian of orphanin FQ/nociceptin and its fragments
32. Analysis of the effects of cyclooxygenase (COX)-1 and COX-2 in spinal nociceptive transmission using indomethacin, a non-selective COX inhibitor, and NS-398, a COX-2 selective inhibitor